Natural Killer Repertoire Restoration in TB/HIV Co-Infected Individuals Experienced an Immune Reconstitution Syndrome (CAMELIA Trial, ANRS 12153).

HIV NK cells antiretroviral treatment immune reconstitution immune reconstitution inflammatory syndrome tuberculosis

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
13 Oct 2023
Historique:
received: 25 08 2023
revised: 06 10 2023
accepted: 07 10 2023
medline: 27 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

IRIS is a common complication in HIV-infected patients treated for tuberculosis (TB) and cART. Our aim was to evaluate NK cell reconstitution in HIV-infected patients with TB-IRIS compared to those without IRIS. 147 HIV-infected patients with TB from the CAMELIA trial were enrolled. HIV+TB+ patients were followed for 32 weeks. The NK cell repertoire was assessed in whole blood at different time points. As CAMELIA has two arms (early and late cART initiation), we analysed them separately. At enrolment, individuals had low CD4 cell counts (27 cells/mm

Identifiants

pubmed: 37887757
pii: pathogens12101241
doi: 10.3390/pathogens12101241
pmc: PMC10610037
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : ANRS
ID : 12153

Références

Front Immunol. 2018 Aug 13;9:1869
pubmed: 30150991
PLoS One. 2015 Mar 26;10(3):e0121019
pubmed: 25811634
Lancet. 2002 Jun 15;359(9323):2059-64
pubmed: 12086758
Curr Opin HIV AIDS. 2018 Nov;13(6):512-521
pubmed: 30124473
Life (Basel). 2020 Oct 29;10(11):
pubmed: 33138069
Clin Exp Immunol. 2021 Apr;204(1):32-40
pubmed: 33315236
Tuberculosis (Edinb). 2001;81(5-6):343-52
pubmed: 11800585
Antivir Ther. 2005;10(3):417-22
pubmed: 15918332
Blood. 2012 Apr 5;119(14):3315-20
pubmed: 22343919
Eur J Immunol. 2003 Sep;33(9):2410-8
pubmed: 12938217
Mucosal Immunol. 2017 Jul;10(4):1031-1042
pubmed: 27924822
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7729-34
pubmed: 22547814
PLoS One. 2008 Apr 09;3(4):e1975
pubmed: 18398485
Nat Rev Immunol. 2022 Feb;22(2):112-123
pubmed: 34117484
J Infect Dis. 2023 Jul 14;228(2):111-115
pubmed: 37040388
Tuberculosis (Edinb). 2009 Dec;89 Suppl 1:S77-80
pubmed: 20006312
AIDS Res Ther. 2018 Mar 15;15(1):7
pubmed: 29544508
Front Cell Infect Microbiol. 2020 Mar 25;10:102
pubmed: 32269968
Blood. 2010 Nov 11;116(19):3818-27
pubmed: 20660788
BMC Immunol. 2014 Jan 31;15:2
pubmed: 24483185
Eur Respir J. 2011 May;37(5):1248-59
pubmed: 20817712
Immunol Lett. 2013 Apr;152(1):16-24
pubmed: 23538009
J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):221-229
pubmed: 29135655
Front Immunol. 2017 Aug 04;8:930
pubmed: 28824650
Nature. 2018 Aug;560(7720):644-648
pubmed: 30135583
Immunobiology. 2000 Aug;202(2):172-8
pubmed: 10993291
Front Immunol. 2017 Jun 30;8:731
pubmed: 28713370
PLoS One. 2017 Jan 11;12(1):e0167640
pubmed: 28076376
PLoS One. 2012;7(6):e37448
pubmed: 22715368
Nat Immunol. 2015 Sep;16(9):927-32
pubmed: 26193080
Sci Rep. 2019 Feb 6;9(1):1502
pubmed: 30728405
Lancet Microbe. 2023 Jan;4(1):e20
pubmed: 36521512
J Immunol. 2005 Nov 15;175(10):6852-60
pubmed: 16272343
Front Cell Infect Microbiol. 2020 Mar 24;10:120
pubmed: 32266170
Tuberculosis (Edinb). 2019 Sep;118:101863
pubmed: 31561185
AIDS. 2007 Dec;21 Suppl 8:S9-17
pubmed: 18172398
Int Immunol. 2009 Jul;21(7):779-91
pubmed: 19461127
Chin Med J (Engl). 2020 Nov 25;133(24):2928-2939
pubmed: 33252378
Front Immunol. 2018 Oct 17;9:2290
pubmed: 30386329
Cell Host Microbe. 2021 Feb 10;29(2):165-178.e8
pubmed: 33340449
PLoS One. 2009;4(5):e5575
pubmed: 19440326
Nat Commun. 2015 Sep 24;6:8451
pubmed: 26399326
Per Med. 2018 Jul 1;15(4):251-269
pubmed: 29984631
J Exp Med. 1993 Dec 1;178(6):2249-54
pubmed: 7504064
Front Immunol. 2019 Aug 13;10:1800
pubmed: 31456797
Front Immunol. 2019 Aug 27;10:2018
pubmed: 31507608
J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):309-18
pubmed: 21826013
AIDS Res Hum Retroviruses. 2008 Nov;24(11):1435-43
pubmed: 19000024
Clin Immunol. 2019 Apr;201:55-60
pubmed: 30817998
AIDS. 2007 Jan 30;21(3):293-305
pubmed: 17255736
Future Microbiol. 2015;10(6):1077-99
pubmed: 26059627
Front Cell Infect Microbiol. 2022 Sep 20;12:962059
pubmed: 36204643
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15011-6
pubmed: 14645713
AIDS. 2013 Oct 23;27(16):2577-86
pubmed: 24096631
AIDS. 2010 Jan 2;24(1):27-34
pubmed: 19910789
J Virol. 2019 Mar 21;93(7):
pubmed: 30700608
EBioMedicine. 2020 Mar;53:102686
pubmed: 32114394
PLoS Pathog. 2014 Oct 02;10(10):e1004433
pubmed: 25275318
N Engl J Med. 2011 Oct 20;365(16):1471-81
pubmed: 22010913

Auteurs

Polidy Pean (P)

Immunology Unit, Institute Pasteur du Cambodge, Phnom Pen 12000, Cambodia.

Yoann Madec (Y)

Epidemiology of Emerging Diseases, Institut Pasteur, Université de Paris, 75000 Paris, France.

Eric Nerrienet (E)

Institut Pasteur, 75000 Paris, France.

Laurence Borand (L)

Clinical Research Team, Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phom Penh 12000, Cambodia.
Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 20600, USA.

Didier Laureillard (D)

Infectious and Tropical Diseases Department, University Hospital, 30900 Nimes, France.

Marcelo Fernandez (M)

Médecins Sans Frontières, 1200 Geneva, Switzerland.

Olivier Marcy (O)

Research Institute for Sustainable Development (IRD) EMR 271, National Institute for Health and Medical Research (INSERM) UMR 1219, University of Bordeaux, 33000 Bordeaux, France.

Daniel Scott-Algara (D)

Unité de Biologie Cellulaire et Lymphocytes, Institut Pasteur, 75000 Paris, France.

Classifications MeSH